🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
"This phase I trial investigates the effect of radiation therapy on the imm...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2022-06-20
Trial ID
NCT05371132
A Phase I/IIa First-in-human, Open-label Study to Evaluate the Safety, Phar...
Status
Terminated
Location
Research Site
Start Date
2022-06-07
Trial ID
NCT05397171
Treatments Being Tested
Background: Multiple sclerosis (MS) and progressive multifocal leukoenceph...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2023-10-19
Trial ID
NCT05849467
Treatments Being Tested
The purpose of this study to learn whether PET/CT (positron emission tomogr...
Status
Completed
Location
Memorial Sloan Kettering at Basking Ridge (Consent Only)
Start Date
2025-03-03
Trial ID
NCT06863233
Treatments Being Tested
This phase I trial studies how well zirconium (Zr)-89 crefmirlimab berdoxam...
Status
Recruiting
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2024-12-05
Trial ID
NCT06650163
This is a multi-center, single-arm trial designed to evaluate the safety an...
Status
Recruiting
Location
VUMC
Start Date
2025-03-11
Trial ID
NCT06534190
Treatments Being Tested
Zr-89 crefmirlimab berdoxam is a Zirconium-89 labelled minibody developed b...
Status
Terminated
Location
Castle Hill Hospital
Start Date
2023-02-16
Trial ID
NCT05744128
Treatments Being Tested
Study of Zirconium Zr 89 Crefmirlimab Berdoxa PET/CT as an imaging biomarke...
Status
Active Not Recruiting
Location
Perleman Center for Advanced Medicine
Start Date
2022-03-08
Trial ID
NCT05279027
Treatments Being Tested
The purpose of this study is to evaluate whether zirconium Zr 89 crefmirlim...
Status
Unknown
Location
CARTI Cancer Center
Start Date
2021-12-09
Trial ID
NCT05013099
Treatments Being Tested